SOPHiA GENETICS provides a cloud-based software platform that analyzes genomic and multimodal clinical data to support precision medicine. Hospitals, laboratories, and biopharma partners use its tools for applications such as oncology, rare disease, and hereditary disorder testing. The company combines data analytics and artificial intelligence to standardize complex molecular insights across decentralized sites rather than selling diagnostic instruments alone.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q2 2025 | 18.3 | — | -22.4 | — |
| Q3 2025 | 19.5 | — | -20 | — |
| Q4 2025 | 21.7 | — | -19.2 | — |
| Q1 2026 | 21.7 | — | -19.3 | — |
| Q2 2026 | 23.3 | 27.2% | -22.4 | — |
All markets — KeepWinning global stock screener
Other companies on Nasdaq: Shenandoah Telecommunications Company (SHEN), DBV Technologies S.A. (DBVT), Sagimet Biosciences Inc. (SGMT), Unity Bancorp, Inc. (UNTY), Kearny Financial Corp. (KRNY), Southern First Bancshares, Inc. (SFST)